Treatment

Friday, 23 October 2009 11:30 - 12:30, Ballroom Le Grand 3

Chair Dr Jim Rodney   
Randomized controlled trial of olanzapine or chlorpromazine as addition to lithium in the treatment of a first manic episode with psychotic features: an 8 weeks, flexible dose, single blind trial
  • Prof Michael Berk, Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Geelong, Australia
From RCT to clinical practice: Implementing and evaluating an effective relapse prevention program for bipolar disorder in community settings
  • Ms Carolynne White, Frameworks for Health, St Vincent's Hospital (Melbourne)
Manic and depressive symptom exacerbation as a function of interaction of dysfunctional attitudes with life events
  • Ms Anet Babakhani, The University of Newcastle